Clinical trial
Open, Prospective, Multicentre Study Addressing the Immediate Benefits and the Prognostic Value of Intraoperative Completion Control Following Infrainguinal Bypass Surgery in Chronic Limb-Threatening Ischemia (CLTI) Patients
NCT06264843 is registered in ClinicalTrials.gov with Medistim ASA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Prospective, Multicentre Study Addressing the Immediate Benefits and the Prognostic Value of Intraoperative Completion Control Following Infrainguinal Bypass Surgery in Chronic Limb-Threatening Ischemia (CLTI) Patients
- Lead sponsor
- Medistim ASA
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 14, 2024
- Completion date
- December 31, 2027
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.